Chemoinformaics analysis of epi-zanthomuurolanine
| Molecular Weight | 583.769 | nRot | 6 |
| Heavy Atom Molecular Weight | 538.409 | nRig | 36 |
| Exact Molecular Weight | 583.33 | nRing | 7 |
| Solubility: LogS | -7.381 | nHRing | 2 |
| Solubility: LogP | 7.552 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 88 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 3 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 45 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 37 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 96.9057 |
| nHD | 0 | BPOL | 55.5343 |
| QED | 0.271 |
| Synth | 4.653 |
| Natural Product Likeliness | 1.866 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.95 |
| HIA | 0.002 |
| CACO-2 | -4.933 |
| MDCK | 0.0000185 |
| BBB | 0.02 |
| PPB | 0.947291 |
| VDSS | 2.069 |
| FU | 0.00471543 |
| CYP1A2-inh | 0.121 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.807 |
| CYP2c19-sub | 0.941 |
| CYP2c9-inh | 0.306 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.312 |
| CYP2d6-sub | 0.931 |
| CYP3a4-inh | 0.819 |
| CYP3a4-sub | 0.924 |
| CL | 11.395 |
| T12 | 0.014 |
| hERG | 0.232 |
| Ames | 0.105 |
| ROA | 0.232 |
| SkinSen | 0.243 |
| Carcinogencity | 0.408 |
| EI | 0.006 |
| Respiratory | 0.589 |
| NR-Aromatase | 0.88 |
| Antiviral | Yes |
| Prediction | 0.923569 |